Cellectis
CLLS
37 hedge funds and large institutions have $96.1M invested in Cellectis in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 11 closing their positions.
16.05% more ownership
Funds ownership: 0% → 16.05% (+16%)
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
9% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 11
3% less funds holding
Funds holding: 38 → 37 (-1)
40% less capital invested
Capital invested by funds: $160M → $96.1M (-$63.8M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $766K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DA
DSC Advisors
Chicago,
Illinois
|
+$1.06M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$710K |
| 3 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$319K |
| 4 |
Lazard Asset Management
New York
|
+$282K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$272K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$12M |
| 2 |
PA
Perceptive Advisors
New York
|
-$4.32M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$3.69M |
| 4 |
Millennium Management
New York
|
-$2.06M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.24M |
CLLS Hedge Fund Activity: Q4 2016 in Review
37 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2016, worth a combined $96.1M — down 40% from $160M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CLLS and 10 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 9 added.
The largest buyer was DSC Advisors, opening a new position worth an estimated $1.06M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $12M sold.
- 37 institutional investors held Cellectis (CLLS) as of Q4 2016, down from 38 in Q3 2016.
- Funds reported $96.1M of Cellectis stock for Q4 2016, down 40% quarter-over-quarter.
- 10 funds opened new Cellectis positions in Q4 2016 and 11 closed out, a net change of -1 holder.
- The largest Cellectis buyer in Q4 2016 was DSC Advisors, an estimated $1.06M added.
- The largest Cellectis seller in Q4 2016 was Cormorant Asset Management, an estimated $12M sold.
Based on aggregated 13F filings for Q4 2016.